General
Preferred name
DecRVKRcmk
Synonyms
Dec-RVKR-CMK ()
Decanoyl-RVKR-CMK ()
Furin Inhibitor I (trifluoroacetate salt) ()
decanoyl-RVKR-chloromethylketone ()
P&D ID
PD018806
CAS
150113-99-8
Tags
available
covalent binder
drug candidate
Drug indication
Middle East Respiratory Syndrome (MERS)
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Decanoyl-RVKR-CMK is a cell‐permeable and irreversible inhibitor of proprotein convertase (PC) enzymes . The PC family of serine proteases includes furin. Furin-mediated cleavage of HIV-1 envelope glycoprotein 160 (gp160) is essential for fusion of the viral envelope with the host cell membrane .
SARS-CoV-2: Decanoyl-RVKR-CMK inhibits cleavage of SARS-CoV-2 spike protein by furin, at the furin cleavage site, and this translates to an antiviral effect in vitro . (GtoPdb)
SARS-CoV-2: Decanoyl-RVKR-CMK inhibits cleavage of SARS-CoV-2 spike protein by furin, at the furin cleavage site, and this translates to an antiviral effect in vitro . (GtoPdb)
DESCRIPTION
Decanoyl-RVKR-CMK (DecRVKRcmk) inhibits over-expressed gp160 processing and HIV-1 replication[1].
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
0
Organisms
1
Compound Sets
5
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
30
Molecular Weight
743.49
Hydrogen Bond Acceptors
8
Hydrogen Bond Donors
11
Rotatable Bonds
30
Ring Count
0
Aromatic Ring Count
0
cLogP
1.19
TPSA
283.29
Fraction CSP3
0.79
Chiral centers
4.0
Largest ring
0.0
QED
0.02
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Therapeutic Class
Antiviral Agents
Target
HIV
Pathway
Anti-infection
Source data
